346 related articles for article (PubMed ID: 30256818)
1. Ethanol and unsaturated dietary fat induce unique patterns of hepatic ω-6 and ω-3 PUFA oxylipins in a mouse model of alcoholic liver disease.
Warner DR; Liu H; Ghosh Dastidar S; Warner JB; Prodhan MAI; Yin X; Zhang X; Feldstein AE; Gao B; Prough RA; McClain CJ; Kirpich IA
PLoS One; 2018; 13(9):e0204119. PubMed ID: 30256818
[TBL] [Abstract][Full Text] [Related]
2. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
3. Dietary Linoleic Acid and Its Oxidized Metabolites Exacerbate Liver Injury Caused by Ethanol via Induction of Hepatic Proinflammatory Response in Mice.
Warner DR; Liu H; Miller ME; Ramsden CE; Gao B; Feldstein AE; Schuster S; McClain CJ; Kirpich IA
Am J Pathol; 2017 Oct; 187(10):2232-2245. PubMed ID: 28923202
[TBL] [Abstract][Full Text] [Related]
4. Omega-6 and omega-3 oxylipins are implicated in soybean oil-induced obesity in mice.
Deol P; Fahrmann J; Yang J; Evans JR; Rizo A; Grapov D; Salemi M; Wanichthanarak K; Fiehn O; Phinney B; Hammock BD; Sladek FM
Sci Rep; 2017 Oct; 7(1):12488. PubMed ID: 28970503
[TBL] [Abstract][Full Text] [Related]
5. Saturated and Unsaturated Dietary Fats Differentially Modulate Ethanol-Induced Changes in Gut Microbiome and Metabolome in a Mouse Model of Alcoholic Liver Disease.
Kirpich IA; Petrosino J; Ajami N; Feng W; Wang Y; Liu Y; Beier JI; Barve SS; Yin X; Wei X; Zhang X; McClain CJ
Am J Pathol; 2016 Apr; 186(4):765-76. PubMed ID: 27012191
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of an endogenous enrichment in n3-PUFAs on Wnt signaling are associated with attenuation of alcohol-mediated liver disease in mice.
Warner DR; Warner JB; Hardesty JE; Song YL; Chen CY; Chen Z; Kang JX; McClain CJ; Kirpich IA
FASEB J; 2021 Feb; 35(2):e21377. PubMed ID: 33481293
[TBL] [Abstract][Full Text] [Related]
7. The role of SHP/REV-ERBα/CYP4A axis in the pathogenesis of alcohol-associated liver disease.
Yang Z; Smalling RV; Huang Y; Jiang Y; Kusumanchi P; Bogaert W; Wang L; Delker DA; Skill NJ; Han S; Zhang T; Ma J; Huda N; Liangpunsakul S
JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34423788
[TBL] [Abstract][Full Text] [Related]
8. NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease.
Li Y; Chen M; Zhou Y; Tang C; Zhang W; Zhong Y; Chen Y; Zhou H; Sheng L
Theranostics; 2020; 10(8):3579-3593. PubMed ID: 32206109
[No Abstract] [Full Text] [Related]
9. Decreased ω-6:ω-3 PUFA ratio attenuates ethanol-induced alterations in intestinal homeostasis, microbiota, and liver injury.
Warner DR; Warner JB; Hardesty JE; Song YL; King TN; Kang JX; Chen CY; Xie S; Yuan F; Prodhan MAI; Ma X; Zhang X; Rouchka EC; Maddipati KR; Whitlock J; Li EC; Wang GP; McClain CJ; Kirpich IA
J Lipid Res; 2019 Dec; 60(12):2034-2049. PubMed ID: 31586017
[TBL] [Abstract][Full Text] [Related]
10. Transient receptor potential vanilloid 1 gene deficiency ameliorates hepatic injury in a mouse model of chronic binge alcohol-induced alcoholic liver disease.
Liu H; Beier JI; Arteel GE; Ramsden CE; Feldstein AE; McClain CJ; Kirpich IA
Am J Pathol; 2015 Jan; 185(1):43-54. PubMed ID: 25447051
[TBL] [Abstract][Full Text] [Related]
11. Profiling the oxylipidome in aged mice after chronic ethanol feeding: Identifying lipid metabolites as drivers of hepatocyte stress.
Anton PE; Rutt LN; Capper C; Orlicky DJ; McCullough RL
Alcohol; 2023 Mar; 107():119-135. PubMed ID: 36150611
[TBL] [Abstract][Full Text] [Related]
12. Mouse Model of Alcoholic Steatohepatitis.
Bertola A
Methods Mol Biol; 2020; 2164():145-157. PubMed ID: 32607891
[TBL] [Abstract][Full Text] [Related]
13. Dietary polyunsaturated fatty acids (C18:2 omega6 and C18:3 omega3) do not suppress hepatic lipogenesis.
Sealls W; Gonzalez M; Brosnan MJ; Black PN; DiRusso CC
Biochim Biophys Acta; 2008 Aug; 1781(8):406-14. PubMed ID: 18655845
[TBL] [Abstract][Full Text] [Related]
14. Dietary n-3 long chain PUFA supplementation promotes a pro-resolving oxylipin profile in the brain.
Rey C; Delpech JC; Madore C; Nadjar A; Greenhalgh AD; Amadieu C; Aubert A; Pallet V; Vaysse C; Layé S; Joffre C
Brain Behav Immun; 2019 Feb; 76():17-27. PubMed ID: 30086401
[TBL] [Abstract][Full Text] [Related]
15. Dietary omega-3 and omega-6 polyunsaturated fatty acids modulate hepatic pathology.
Khadge S; Sharp JG; Thiele GM; McGuire TR; Klassen LW; Duryee MJ; Britton HC; Dafferner AJ; Beck J; Black PN; DiRusso CC; Talmadge J
J Nutr Biochem; 2018 Feb; 52():92-102. PubMed ID: 29175671
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 polyunsaturated fatty acids ameliorate ethanol-induced adipose hyperlipolysis: A mechanism for hepatoprotective effect against alcoholic liver disease.
Wang M; Zhang X; Ma LJ; Feng RB; Yan C; Su H; He C; Kang JX; Liu B; Wan JB
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3190-3201. PubMed ID: 28847514
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between gut microbiota and host lipid metabolism in a mouse model of alcoholic liver injury by chronic baijiu or ethanol feeding.
Fang C; Zhou Q; Liu Q; Jia W; Xu Y
Food Funct; 2022 Jan; 13(2):596-608. PubMed ID: 34927188
[TBL] [Abstract][Full Text] [Related]
18. Lowering the dietary omega-6: omega-3 does not hinder nonalcoholic fatty-liver disease development in a murine model.
Enos RT; Velázquez KT; McClellan JL; Cranford TL; Walla MD; Murphy EA
Nutr Res; 2015 May; 35(5):449-59. PubMed ID: 25934114
[TBL] [Abstract][Full Text] [Related]
19. Binge ethanol and liver: new molecular developments.
Shukla SD; Pruett SB; Szabo G; Arteel GE
Alcohol Clin Exp Res; 2013 Apr; 37(4):550-7. PubMed ID: 23347137
[TBL] [Abstract][Full Text] [Related]
20. Serum and Fecal Oxylipins in Patients with Alcohol-Related Liver Disease.
Gao B; Lang S; Duan Y; Wang Y; Shawcross DL; Louvet A; Mathurin P; Ho SB; Stärkel P; Schnabl B
Dig Dis Sci; 2019 Jul; 64(7):1878-1892. PubMed ID: 31076986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
